The case
For Pharming, the biotech company developing therapies for rare immune and genetic diseases and listed on both Euronext Amsterdam and Nasdaq, we run the complete online strategy. From positioning and content structure to a custom website on Next.js and Sanity.
One platform for three very different audiences: patients and their families, the healthcare professionals around them, and the international investor market. Strategy, design, development and hosting all sit with us under one roof.
The result
A blazing-fast custom site where patient stories, the clinical pipeline and investor relations live side by side without getting in each other's way. The editorial team publishes directly in Sanity, with no development handoff.
Structured pipeline and therapy data around RUCONEST and JOENJA, an investor section that fits the obligations of a dual listing, and interstitials that warn visitors the moment a link takes them to a US-specific or external source.
The solution
Next.js for performance and discoverability, Sanity as the headless CMS for the editorial team, and hosting and monitoring that we manage ourselves. One technical foundation the brand can keep building on for years.
Because hosting sits with us too, there is no third party between strategy and execution. New content, new pages and releases all go live through one line, in a sector where care around communication weighs heavier than speed.
